Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants.

  • Authors : Zarn KE; Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.; Jaramillo SA

Subjects: Poly(ADP-ribose) Polymerases*/Poly(ADP-ribose) Polymerases*/Poly(ADP-ribose) Polymerases*/metabolism ; COVID-19 Drug Treatment*; Adenosine Diphosphate SARS-CoV-2 variants

  • Source: PloS one [PLoS One] 2022 Sep 14; Vol. 17 (9), pp. e0272916. Date of Electronic Publication: 2022 Sep 14 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-1 of  1 results for ""COVID-19 Testing""